SUGDIS Publication Issue Titles
2006

To jump to a specific SUGDIS publication, click on the title:

CLIPs--Current Literature and Information for Pharmacists
New Drug FAX Sheet
Pharmacy Precis
Index, 4th Qtr

CLIPs--Current Literature and Information for Pharmacists:
2006, Vol 10

Issue
Number

Date

Title

67
Dec 25 Drug-Induced Emergency Department Visits
66
Dec 18 Child and Adolescent Food and Nutrition Programs
65
Dec 4 Pressure Ulcer Guideline Review
64
Nov 27 Assessment of GI Bleeding Risk with Low-Dose Aspirin
63
Nov 20 Assessment of Renal Function in Clinical Practice
62
Nov 8 Current Trends in Treating Osteoporosis
61
Nov 6 Diagnosis and Management of Anaphylaxis
60
Oct 30 Drug Overdose & Antidotes
59
Oct 27 Atypical Antipsychotics and Alzheimer's Disease
58
Oct 23 Benefits and Safety of Intensive Statin Therapy
57
Oct 16 NIH Recommendations for Multivitamin/Mineral Supplements to Prevent Chronic Diseases
56
Oct 13 Influenza Vaccination for Patients with CVD
55
Oct 2 Management of Atrial Fibrillation: 2006 ACC/AHA/ESC Guidelines
54
Sep 25 Improved Aminosalicylate Formulations to Treat UC
53
Sep 19 Updated CDC Guidelines: Treatment of Sexually Transmitted Diseases

52

Sep 11

Fluoroquinolones' Activity vs. Anaerobes

51

Sep 8

Useful Alternative for Post-Op Nausea and Vomiting

50

Sep 4

Initial Insulin Therapy Guidelines for Diabetic Patients

49

Aug 21

GERD: Diagnosis and Treatment

48

Aug 14

Obesity: A Matter of Public Health?

47

Aug 11

Non-Estrogen Therapies for Menopausal Hot Flashes

46

Aug 9

Long-Term Safety of Bisphosphonate Therapy

45

Jul 31

Updated AHA Guidelines: Pediatric Basic Life Support

44

Jul 27

Preventing Contrast-Induced Nephropathy

43

Jul 25

Falls Prevention in Ling-Term Care: An Interdisciplinary Aproach

42

Jul 24

Updated Secondary Prevention Guidelines

41

Jul 17

ASHP Position Statement: 0.9% Sodium Chloride Use to Maintain Catheter Patency

40

Jul 14

Another Raloxifene Breast Cancer Prevention Study

39

Jul 7

Raloxifene for Breast Cancer Prevention

38

Jul 3

Current Antifungal Therapy

37

Jun 26

Review of Clinical Pharmacists Value in Inpatient Medical Care

36

Jun 22

Neuroprotective Strategies for Parkinson Disease

35

Jun 19

AHA / ASA Guidelines for Stroke Prevention

34

Jun 12

Pharmacists and Cardiovascular Disease

33

Jun 5

Restless Legs Syndrome and Periodic Limb Movement Disorder

32

May 29

Obesity and Weight Loss: A Review of Drug Safety

31

May 22

Obesity and Cardiovascular Disease

30

May 8

Issues of Pediatric Sedation and Analgesia

29

May 1

Disinfecting Agents, Procedures, & Requirements for Cleanrooms

28

Apr 27

Pressure Ulcer Assessment & Guidelines

27

Apr 26

Preventing and Treating Pressure Ulcers

26

Apr 25

Aspirin and NSAIDs: Physician Perceptions

25

Apr 24

Soy Proteins and Isoflavones, Are These Beneficial?

24

Apr 17

Treatment Update for Sinusitis Management

23

Apr 10

Osteoporosis Management in the the Elderly

22

Apr 3

Allergies and Antibiotics

21

Mar 28

Bad Bugs, Bad Bugs, Whatcha Gonna Do?

20

Mar 27

Urinary Incontinence

19

Mar 23

Acinetobacter

18

Mar 21

Anti-IgE for Asthma Therapy

17

Mar 20

A Guide to Dietary Recommendations for Youth

16

Mar 16

Clopidogrel (Plavix®) in the News

15

Mar 6

Limited Adverse Events with Excessive Anticoagulation

14

Mar 6

Treating Excessive Anticoagulation with Vitamin K

13

Mar 3

NSAID Use in High-Risk Patients

12

Mar 1

Interaction Between Linezolid and SSRI

11

Feb 27

Methamphetamine Abuse

10

Feb 20

Updated ACCP Guidelines: Cough Suppressant and Protussive Therapy

9

Feb 13

Clarification of Drug Safety Terms

8

Feb 3

Treating Elderly Patients with Diabetes

7

Feb 2

ASHP's Statement Regarding OTC Statins

6

Jan 30

Drug-Induced Emergency Room Visits

5

Jan 27

Panel Recommendations for Factor VIIA Use

4

Jan 23

Nesiritide Use in Outpatient Setting

3

Jan 17

A Year in Review: Heart Failure 2005 and Beyond

2

Jan 9

Candida and Invasive Mold Infections

Jan 2

Diabetic Foot Ulcers

Return to Top

New Drug FAX Sheet:
2006, Vol 11

Issue 
Number

Date

Title

52
Dec 19 FDA Alert for Viral Infection of the Brain After Rituximab (Rituxan®) Administration
51
Dec 13 FDA Warns Against Unlabeled Drugs Uses for Quinine Products
50
Dec 11 New Drug Approvals
49
Nov 28 Serious Adverse Effects Associated with Methadone therapy
48
Nov 17

Serious Cardiovascular Complications Associated with Erythropoiesis-Stimulating Agents at Higher Target Hemoglobin Concentrations

47
Nov 14 Tamiflu (Oseltamivir) Neuropsychiatric Events in Children
46
Nov 13 New Drug Approvals
45
Nov 10 Acetaminophen Recall
44
Oct 9 New Drug Approvals
43
Oct 2 Trasylol® Warning
42
Sep 25 Ortho Evra Warning

41

Sep 14

Ibuprofen and Aspirin Combination Warning

40

Sep 14

Dietary Supplements Seized

39

Sep 7

Dietary Supplements with Ephedrine Banned

38

Aug 28

New Drug Approvals

37

Aug 22

New Warnings for Stimulants

36

Aug 11

Hydralazine Injection Recall

35

Aug 7

New Drug Approvals, Formulations, and Indications

34

Jul 20

Serotonin Syndrome Associated with Concomitant Use of Triptans and SSRIs or SNRIs

33

Jul 20

Adverse Effects Associated with SSRI Treatment in Pregnancy

32

Jul 11

Oxybutynin Transdermal (Oxytrol®, Watson Pharma)

31

Jul 10

New Drug Approvals

30

Jul 3

Intracranial Hemorrhage Associated with Tipranavir (Aptivus®) Use

29

Jun 30

FDA Issues Warnings of Liver Toxicity for Telithromycin (Ketek®)

28

Jun 23

Tequin® (Gatifloxacin) Discontinued

27

Jun 7

Resumed Marketing of Natalizumab (Tysabri®)

26

May 18

Exubera® (Insulin Human [RDNA Origin] Inhalation Powder)

25

May 15

New Drug Approvals

24

May 8

Phosphate Nephropathy and Oral Sodium Phosphates

23

Apr 26

Promethazine and Respiratory Depression

22

Apr 10

Reports of Anaphylaxis with Macugen® (Pegaptanib) Therapy

21

Apr 10

New Drug Approvals

20

Mar 31

New Information Concerning Diastat® AcuDial (Diazepam Rectal Gel) Administration

19

Mar 17

Two Additional Fatalities Associated with Mifepristone (Mifeprex®) for Medical Abortion

18

Mar 16

Denileukin Difititox (Ontak®)--Associated Visual Loss

17

Mar 13

New Drug Approvals

16

Mar 1

Cefazolin for Injection Recall Due to Microbial Contamination

15

Feb 22

Investigational Oral Anticoagulants

14

Feb 17

Ximelagatran (Exanta®) Approval Application Withdrawn 

13

Feb 17

New Safety Alerts for Gatifloxacin (Tequin®) Tablets and Injection

12

Feb 16

New Warnings for Nimodipine (Nimotop®) Capsules

11

Feb 14

Recall of Balanced Salt Solution from Cytosol Laboratories

10

Feb 14

Benzocaine Sprays Used in the Mouth or Throat and Methemoglobinemia

9

Feb 6

New Drug Approvals

8

Jan 27

Hydroxyurea (Hydrea® ) Associated with Vasculitic Ulcerations

7

Jan 24

Ketek (Telithromycin) Associated with Liver Toxicity

6

Jan 24

Elidel (Pimecrolimus) Reserved as a Second-Line Agent for Atopic Dermatitis

5

Jan 18

Influenza Update: Amantadine and Rimantadine Not Recommended

4

Jan 17

Dangerous Diet Pills

3

Jan 17

Revisions to Clozaril® Package Labeling

2

Jan 6

Intravascular Hemolyisis and Blood Glucose Alterations Associated with WinRho® SDF Therapy

Jan 5 

Rosiglitazone-Associated Diabetic Macular Edema 

Return to Top

Pharmacy Precis:
2006, Vol 24

Issue 
Number

Date

Title

3
Oct Advisory Committee on Immunization Practices (ACIP) Recommendations for the Prevention and Control of Influenza

2

Jun

SUGDIS 2005: Quality Assurance Survey Results

Jan

New Molecular Entities of 2005

Back to SUGDIS Publications